Correlation Between Karyopharm Therapeutics and Sonnet Biotherapeutics
Can any of the company-specific risk be diversified away by investing in both Karyopharm Therapeutics and Sonnet Biotherapeutics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Karyopharm Therapeutics and Sonnet Biotherapeutics into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Karyopharm Therapeutics and Sonnet Biotherapeutics Holdings, you can compare the effects of market volatilities on Karyopharm Therapeutics and Sonnet Biotherapeutics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Karyopharm Therapeutics with a short position of Sonnet Biotherapeutics. Check out your portfolio center. Please also check ongoing floating volatility patterns of Karyopharm Therapeutics and Sonnet Biotherapeutics.
Diversification Opportunities for Karyopharm Therapeutics and Sonnet Biotherapeutics
0.36 | Correlation Coefficient |
Weak diversification
The 3 months correlation between Karyopharm and Sonnet is 0.36. Overlapping area represents the amount of risk that can be diversified away by holding Karyopharm Therapeutics and Sonnet Biotherapeutics Holding in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Sonnet Biotherapeutics and Karyopharm Therapeutics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Karyopharm Therapeutics are associated (or correlated) with Sonnet Biotherapeutics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Sonnet Biotherapeutics has no effect on the direction of Karyopharm Therapeutics i.e., Karyopharm Therapeutics and Sonnet Biotherapeutics go up and down completely randomly.
Pair Corralation between Karyopharm Therapeutics and Sonnet Biotherapeutics
Given the investment horizon of 90 days Karyopharm Therapeutics is expected to generate 0.29 times more return on investment than Sonnet Biotherapeutics. However, Karyopharm Therapeutics is 3.46 times less risky than Sonnet Biotherapeutics. It trades about -0.71 of its potential returns per unit of risk. Sonnet Biotherapeutics Holdings is currently generating about -0.38 per unit of risk. If you would invest 84.00 in Karyopharm Therapeutics on September 26, 2024 and sell it today you would lose (24.00) from holding Karyopharm Therapeutics or give up 28.57% of portfolio value over 90 days.
Time Period | 3 Months [change] |
Direction | Moves Together |
Strength | Very Weak |
Accuracy | 100.0% |
Values | Daily Returns |
Karyopharm Therapeutics vs. Sonnet Biotherapeutics Holding
Performance |
Timeline |
Karyopharm Therapeutics |
Sonnet Biotherapeutics |
Karyopharm Therapeutics and Sonnet Biotherapeutics Volatility Contrast
Predicted Return Density |
Returns |
Pair Trading with Karyopharm Therapeutics and Sonnet Biotherapeutics
The main advantage of trading using opposite Karyopharm Therapeutics and Sonnet Biotherapeutics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Karyopharm Therapeutics position performs unexpectedly, Sonnet Biotherapeutics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Sonnet Biotherapeutics will offset losses from the drop in Sonnet Biotherapeutics' long position.Karyopharm Therapeutics vs. X4 Pharmaceuticals | Karyopharm Therapeutics vs. Hookipa Pharma | Karyopharm Therapeutics vs. Mereo BioPharma Group | Karyopharm Therapeutics vs. Acumen Pharmaceuticals |
Sonnet Biotherapeutics vs. ZyVersa Therapeutics | Sonnet Biotherapeutics vs. Allarity Therapeutics | Sonnet Biotherapeutics vs. Immix Biopharma | Sonnet Biotherapeutics vs. Cns Pharmaceuticals |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Earnings Calls module to check upcoming earnings announcements updated hourly across public exchanges.
Other Complementary Tools
Price Transformation Use Price Transformation models to analyze the depth of different equity instruments across global markets | |
Idea Optimizer Use advanced portfolio builder with pre-computed micro ideas to build optimal portfolio | |
Global Markets Map Get a quick overview of global market snapshot using zoomable world map. Drill down to check world indexes | |
Bond Analysis Evaluate and analyze corporate bonds as a potential investment for your portfolios. | |
Transaction History View history of all your transactions and understand their impact on performance |